Intra-aortic balloon pump use and outcomes with current therapies

Journal of Invasive Cardiology

Volumn 23, Issue 3, 2011, Pages 116-119

  Vales, Lori ^a   Kanei, Yumiko ^a   Ephrem, Georges ^b   Misra, Deepika ^a  

^a Division of Cardiology   (United States)

^b BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; GLYCOPROTEIN IIB IIIA INHIBITOR; HEPARIN; UNCLASSIFIED DRUG;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; ASSISTED CIRCULATION; BLEEDING; CLINICAL EFFECTIVENESS; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; DRUG ELUTING STENT; EMBOLISM; FEMALE; FEVER; HUMAN; INTRA AORTIC BALLOON PUMP THERAPY; LEUKOCYTOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; RETROSPECTIVE STUDY; THROMBOCYTOPENIA; TREATMENT DURATION; VASCULAR ACCESS DEVICE; AORTA BALLOON; CARDIOGENIC SHOCK; COHORT ANALYSIS; HEART INFARCTION; INCIDENCE; MIDDLE AGED; OUTCOME ASSESSMENT; RISK FACTOR; UTILIZATION REVIEW;

AGED; COHORT STUDIES; FEMALE; FEVER; HEMORRHAGE; HOSPITAL MORTALITY; HUMANS; INCIDENCE; INTRA-AORTIC BALLOON PUMPING; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT (HEALTH CARE); RETROSPECTIVE STUDIES; RISK FACTORS; SHOCK, CARDIOGENIC; THROMBOCYTOPENIA;

EID: 79960038179     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Stone GW, Ohman EM, Miller MF, et al. Contemporary utilization and outcomes of intra-aortic balloon counterpulsation in acute myocardial infarction: The benchmark registry. J Am Coll Cardiol 2003;41:1940-1945. (Pubitemid 36677111)
2. Sanborn TA, Sleeper LA, Bates ER, et al., for the SHOCK Investigators. Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: A report from the SHOCK trial registry. J Am Coll Cardiol 2000;36:1123-1129.
3. Sjauw KD, Engstrom AE, Vis MM, et al. A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: Should we change the guidelines?. Eur Heart J 2009;30:459-468.
4. Dyub AM, Whitlock RP, Abouzahr LL, Cina CS. Preoperative intra-aortic balloon pump in patients undergoing coronary bypass surgery: A systematic review and meta-analysis. J Card Surg 2008;23:79-86. (Pubitemid 351286922)
5. Kumbasar SD, Semiz E, Sancaktar O, et al. Mechanical complications of intra-aortic balloon counterpulsation. Int J Cardiol 1999;70:69-73. (Pubitemid 29277114)
6. Gol MK, Bayazit M, Emir M, et al. Vascular complications related to percutaneous insertion of intra-aortic balloon pumps. Ann Thorac Surg 1994;58:1476-1480. (Pubitemid 24347546)
7. Mackenzie DL, Wagner WH, Kulber DA, et al. Vascular complications of the intraaortic balloon pump. Am J Surg 1992;164:517-521. (Pubitemid 23072548)
8. Schreiber TL, Kodali UR, O'Neill WW, et al. Comparison of acute results of prophylactic intra-aortic balloon pumping with cardiopulmonary support for percutaneous transluminal coronary angioplasty. Catheter Cardiovasc Diagn 1998;45:115-119. (Pubitemid 28450205)
9. Bream-Rouwenhorst HR, Hobbs RA, Horwitz PA. Thrombocytopenia in patients treated with heparin, combination antiplatelet therapy and intra-aortic balloon pump counterpulsation. J Intervent Cardiol 2008;21:350-356. (Pubitemid 352033293)
10. Kohsaka S, Menon V, Iwata K, et al., for the SHOCK Investigators. Microbiological profile of septic complications in patients with cardiogenic shock following acute myocardial infarction from the SHOCK study. Am J Cardiol 2007;99:802-804. (Pubitemid 46365600)
11. Crystal E, Borer A, Gilad J, et al. Incidence and clinical significance of bacteremia and sepsis among cardiac patients treated with intra-aortic balloon counterpulsation pump. Am J Cardiol 2000;86:1281-1284.
12. Naito K, Anzai T, Yoshikawa T, et al. Increased body temperature after reperfused acute myocardial infarction is associated with adverse left ventricular remodeling. J Card Fail 2007;13:25-33. (Pubitemid 46330834)
13. Hochman JS. Cardiogenic shock complicating acute myocardial infarction: Expanding the paradigm. Circulation 2003;107:2998-3002. (Pubitemid 36758968)
14. Barron HV, Every NR, Parsons LS, et al., for the Investigators in the National Registry of Myocardial Infarction 2. The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: Data from the National Registry of Myocardial Infarction 2. Am Heart J 2001;141:933-939.
15. Anderson RD, Ohman EM, Holmes DR, et al., for the GUSTO I Investigators. Use of intra-aortic balloon counterpulsation in patients presenting with cardiogenic shock: Observations from the GUSTO-I Study. J Am Coll Cardiol 1997;30:708-715. (Pubitemid 27397651)
16. Ohman EM, Nanas J, Stomel RJ, et al. Thrombolysis and counterpulsation to improve survival in myocardial infarction complicated by hypotension and suspected cardiogenic shock or heart failure: Results of the TACTICS. J Thromb Thrombolysis 2005;19:33-39. (Pubitemid 40959212)
17. Stone GW, Marsalese D, Brodie BR, et al. A prospective randomized evaluation of prophylactic intra-aortic balloon counterpulsation in high risk patients with acute myocardial infarction treated with primary angioplasty. Second Primary Angioplasty in Myocardial Infarction (PAMI II) Trial Investigators. J Am Coll Cardiol 1997;29:1459-1467. (Pubitemid 27272437)
18. Menon V, White H, LeJemtel T, et al., for the SHOCK Investigators. The clinical profile of patients with suspected cardiogenic shock due to predominant left ventricular failure: A report from the SHOCK trial registry. J Am Coll Cardiol 2000;36:1071-1076.
19. Hochman JS, Buller CE, Sleeper LA, et al., for the SHOCK Investigators. Cardiogenic shock complicating acute myocardial infarction - Etiologies, management and outcome: A report from the SHOCK trial registry. J Am Coll Cardiol 2000;36:1063-1070.